Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NSE/JSLL stock hub

NSE/JSLL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/JSLLis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
93B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/JSLL
In the news

Latest news · NSE/JSLL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.2
P25 24.9P50 32.4P75 45.7
Trailing P/E43.8
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC61.3
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/JSLL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
172
Groups with data
10
Currency
INR
Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
India
Country code
IN
Employees
3,764
Employees Change
1,206%
Employees Change Percent
47.15
Enterprise value
INR 92.9B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Medical Care Facilities
Last refreshed
2026-05-10
Market cap
INR 93B
Price
INR 748
Price currency
INR
Rev Per Employee
1,926,305.26x
Sector
Healthcare
Sic
2834
Symbol
nse/JSLL
Website
https://jeenasikho.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
2.29%
EV Earnings
43.65x
EV/EBIT
32.93x
EV/EBITDA
32.02x
EV/Sales
12.81x
Forward P/E
26.2x
P/B ratio
26.31x
P/E ratio
43.77x
P/S ratio
12.83x
PE Ratio3 Y
38.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
38.92%
EBITDA Margin
40.02%
Gross margin
91.01%
Gross Profit
INR 6.6B
Gross Profit Growth
79.19%
Gross Profit Growth Q
97.66%
Gross Profit Growth3 Y
71.26%
Net Income
INR 2.1B
Net Income Growth
190.4%
Net Income Growth Q
404.59%
Net Income Growth3 Y
166.6%
Pretax Margin
39.25%
Profit Margin
29.36%
Profit Per Employee
INR 565,475
Roa5y
24.11
Roe5y
42.96
ROIC
61.32
Roic5y
46.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
Cagr1y
70.21%
Cagr3y
181.98%
EPS Growth
190
EPS Growth Q
404.7
EPS Growth3 Y
140.1
Revenue Growth
75.41x
Revenue Growth Q
91.61x
Revenue Growth3 Y
70.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 1.2B
Debt
INR 1.1B
Debt EBITDA
INR 0.37
Debt Equity
INR 0.3
Equity
INR 3.5B
Interest Coverage
138.3
Net Cash
INR 95.7M
Net Cash By Market Cap
INR 0.1
Net Debt EBITDA
INR -0.03
Net Debt Equity
INR -0.03
Tangible Book Value
INR 2.9B
Tangible Book Value Per Share
INR 23.33
WACC
10.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-0.12%
Dividend Growth
31.58%
Dividend Growth Years
3%
Dividend per share
INR 1.1
Dividend Years
3
Dividend Yield
0.15%
Ex Div Date
2025-09-22
Last Dividend
INR 1.1
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
70.15%
200-day SMA
687.7
3Y total return
2,143.72%
50-day SMA
641.7
50-day SMA vs 200-day SMA
50under200
All Time High
849.5
All Time High Change
-11.92%
All Time High Date
2025-09-23
All Time Low
14.11
All Time Low Change
5,202.6%
All Time Low Date
2022-07-19
ATR
30.69
Beta
1.19
Beta1y
0.35
Beta2y
0.52
Ch YTD
9.93
High
763.8
High52
849.5
High52 Date
2025-09-23
High52ch
-11.92%
Low
730
Low52
376
Low52 Date
2025-05-19
Low52ch
99%
Ma50ch
16.6%
Price vs 200-day SMA
8.8%
RSI
66.96
RSI Monthly
68.2
RSI Weekly
58.29
Sharpe ratio
1.28x
Sortino ratio
2.35
Total Return
0.02%
Tr YTD
9.93
Tr1m
20.72%
Tr1w
9.07%
Tr3m
5.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
INR 2.8B
Operating Income Growth
189.1
Operating Income Growth Q
323.2
Operating Income Growth3 Y
166.3
Operating margin
38.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
38,105,316%
Shares Insiders
65.37%
Shares Institutions
5.8%
Shares Out
124,300,730
Shares Qo Q
0.1%
Shares Yo Y
0.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Average Volume
304,912.25x
Bv Per Share
28.47
Ch1m
20.72
Ch1w
9.07
Ch1y
69.92
Ch3m
5.05
Ch3y
2,129.9
Ch6m
-5.76
Change
1.33%
Change From Open
1.26
Close
738.5
Days Gap
0.07
Depreciation Amortization
79,961,000
Dollar Volume
306,699,444.3
Earnings Date
2026-05-22
EBIT
INR 2.8B
EBITDA
INR 2.9B
EPS
INR 17.09
F Score
2
Fiscal Year End
March
Founded
2,009
Graham Number
104.64002
Graham Upside
-86.02
Income Tax
INR 718.3M
Is Primary Listing
1
Last Earnings Date
2026-02-07
Last Report Date
2025-12-31
Last Split Date
2025-06-12
Last Split Type
Forward
Lynch Fair Value
INR 427
Lynch Upside
-42.88
Ma150
693.6
Ma150ch
7.87%
Ma20
685.4
Ma20ch
9.16%
Next Earnings Date
2026-05-22
Open
739
Payment Date
2025-10-29
Position In Range
53.99
Price Date
2026-05-08
Price EBITDA
INR 32.05
Ptbv Ratio
32.09
Relative Volume
1.34x
Revenue
7,250,613,000x
Tax By Revenue
9.91x
Tax Rate
25.24%
Tr6m
-5.76%
Volume
409,889
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

NSE/JSLL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.1%
$1.10 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
3 consecutive years of growth
Total shareholder yield
+0.0%
Next ex-dividend date: 2025-09-22
Performance

NSE/JSLL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+70.1%
S&P 500 1Y: n/a
3Y total return
+2143.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/JSLL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+5.8%
Share of float held by funds and institutions
Insider ownership
+65.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.1%
Negative means the company is buying back shares.
Technical

NSE/JSLL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
67.0
Neutral momentum band
Price vs 200-day MA
+8.8%
50/200-day relationship not available
Beta (5Y)
1.19
Moves roughly with the market
Sharpe ratio
1.28
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/JSLL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/JSLL stock rating?

nse/JSLL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/JSLL analysis?

The full report lives at /stocks/nse/JSLL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/JSLL?

The latest report frames nse/JSLL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/JSLL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.